Form SC 13G/A BRUKER CORP Filed by: FMR LLC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
JPMorgan Upgrades Bruker (BRKR) to Overweight
February 13, 2024 4:24 PM ESTJPMorgan analyst Tycho W. Peterson upgraded Bruker (NASDAQ: BRKR) from Neutral to Overweight with a price target of $90.00 (from $60.00).
The analyst comments "This morning, Bruker (BRKR) reported a sizeable 4Q beat while initiating better-than-expected 2024 guidance and, most notably, pulled forward its 2026 revenue and non-GAAP EPS LRP targets to 2025 (implying >30% non-GAAP EPS growth in 2025). Strength across regions and end-markets is driven by secular trends in proteomics and other omics research in what the company describes as the... More
